Preprint · OA
via OpenAlex
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration
Daniel Francis Martin, Maureen G. Maguire, Stuart L. Fine, Gui‐Shuang Ying, Glenn J. Jaffe, Juan E. Grunwald, Cynthia Ann Toth, Maryann Redford, Frederick L. Ferris
Ophthalmology · 2012 · ▲ 1,713 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.ophtha.2012.03.053
- Canonical
- link ↗
- Fetched
- 2026-10-19 MST
Cite this
APA
Martin, D.F., Maguire, M.G., Fine, S.L., Ying, G., Jaffe, G.J., Grunwald, J.E., Toth, C.A., Redford, M., & Ferris, F.L. (2012). Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. <em>Ophthalmology</em>. https://doi.org/10.1016/j.ophtha.2012.03.053
Vancouver
Martin DF, Maguire MG, Fine SL, Ying G, Jaffe GJ, Grunwald JE, et al. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. Ophthalmology. 2012. doi:10.1016/j.ophtha.2012.03.053.
BibTeX
@unpublished{daniel2012Ranibi,
title = {Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration},
author = {Daniel Francis Martin and Maureen G. Maguire and Stuart L. Fine and Gui‐Shuang Ying and Glenn J. Jaffe and Juan E. Grunwald and Cynthia Ann Toth and Maryann Redford and Frederick L. Ferris},
journal = {Ophthalmology},
year = {2012},
doi = {10.1016/j.ophtha.2012.03.053},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ophthalmology 2006
Citation only
Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration
Drugs 2008
Citation only
Neovascular Age-Related Macular Degeneration
Nature reviews. Immunology 2013
Preprint · OA
Immunology of age-related macular degeneration
American Journal of Ophthalmology 2007
Citation only
Ranibizumab According to Need: A Treatment for Age-related Macular Degeneration
Ophthalmology 2006
Citation only
Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration
Control Delivery Systems 2001
Open access · US-GOV